Revisions to Brazil's drug price framework are coming - what's included and what's missing? Our analysts provide th… https://t.co/8s17gnKCXf
ISPOR 2018 Baltimore
We are pleased to announce that we will be at ISPOR 2018, 19-23 May, in Baltimore, Maryland. Please do look out for members of our team to learn about our Connect platform, our new tendering service, and recent product developments.
We have two posters going up on Tuesday, 22 May. Both will be up from 8:30am - 2:00pm and you can hear our researchers present them from 1:00pm - 2:00pm.
- In aisle A21, PHP22: Towards IPR common ground: To what extent are European countries aligned in how they use International Reference Pricing? by Cameron Lockwood (who will be presenting) , Tania Rodrigues, Choukri Genane, Wayne Su, and Gustav Ando
- In aisle C36, PHP133: Designing evidence generated plans for digital health technologies to gain reimbursement coverage in the US by Wayne Su (who will be presenting), Cameron Lockwood, and Frank Chen
If you would prefer, request a meeting with us ahead of time by emailing us at ECR@ihsmarkit.com.
We'll be blogging and tweeting from the event so stay tuned!
- Brazil finally edges towards first drug pricing reform after two years – is it a missed opportunity?
- Variations on an IRP theme: How payers are repurposing pricing policies for new categories of medicines
- Pharmaceutical and healthcare sectors jointly top global PMI ranking for first time
- Will physicians become more difficult to find in America?
- California's Medicaid pharmacy "carve-out" set to boost state's negotiating power, introduce IRP for drugs
- Trend towards HTA collaboration boosts need for data
- Barriers to market access for innovative medicines increase in the COVID era
- ESG permeates pharmaceutical pricing strategy
Major changes to Czech P&R regulations for orphan and high-cost drugs set to expand access. What role will IRP play… https://t.co/bQcVCG5jut